Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Newman

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Cancer|January 10, 2001
Reduction in fat intake is not associated with weight loss in most women after breast cancer diagnosis: evidence from a randomized controlled trialC L Rock, C Thomson, B J Caan, et al.
Elife|February 21, 2022
P2Y1 purinergic receptor identified as a diabetes target in a small-molecule screen to reverse circadian β-cell failureBiliana Marcheva, Benjamin J Weidemann, Akihiko Taguchi, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Discovery of bacterial NAD⁺-dependent DNA ligase inhibitors: improvements in clearance of adenosine seriesSuzanne S Stokes, Madhusudhan Gowravaram, Hoan Huynh, et al.
Nature Communications|September 16, 2024
Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma modelsWilliam Senapedis, Kayleigh M Gallagher, Elmer Figueroa, et al.
The Journal of Endocrinology|September 18, 2010
Regulation of pancreatic islet gene expression in mouse islets by pregnancyB T Layden, V Durai, M V Newman, et al.
Cell Metabolism|January 3, 2024
Repression of latent NF-κB enhancers by PDX1 regulates β cell functional heterogeneityBenjamin J Weidemann, Biliana Marcheva, Mikoto Kobayashi, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2010
Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivoScott D Mills, Ann E Eakin, Ed T Buurman, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2017
The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus MacaquesTrudy H Grossman, Michael S Anderson, Lindsay Drabek, et al.
Science (New York, N.Y.)|October 20, 2022
Time-restricted feeding mitigates obesity through adipocyte thermogenesisChelsea Hepler, Benjamin J Weidemann, Nathan J Waldeck, et al.
Journal of Medicinal Chemistry|May 16, 2014
Antibacterial inhibitors of Gram-positive thymidylate kinase: structure-activity relationships and chiral preference of a new hydrophobic binding regionSameer P Kawatkar, Thomas A Keating, Nelson B Olivier, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Cancer|January 10, 2001
Reduction in fat intake is not associated with weight loss in most women after breast cancer diagnosis: evidence from a randomized controlled trialC L Rock, C Thomson, B J Caan, et al.
Elife|February 21, 2022
P2Y1 purinergic receptor identified as a diabetes target in a small-molecule screen to reverse circadian β-cell failureBiliana Marcheva, Benjamin J Weidemann, Akihiko Taguchi, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Discovery of bacterial NAD⁺-dependent DNA ligase inhibitors: improvements in clearance of adenosine seriesSuzanne S Stokes, Madhusudhan Gowravaram, Hoan Huynh, et al.
Nature Communications|September 16, 2024
Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma modelsWilliam Senapedis, Kayleigh M Gallagher, Elmer Figueroa, et al.
The Journal of Endocrinology|September 18, 2010
Regulation of pancreatic islet gene expression in mouse islets by pregnancyB T Layden, V Durai, M V Newman, et al.
Cell Metabolism|January 3, 2024
Repression of latent NF-κB enhancers by PDX1 regulates β cell functional heterogeneityBenjamin J Weidemann, Biliana Marcheva, Mikoto Kobayashi, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2010
Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivoScott D Mills, Ann E Eakin, Ed T Buurman, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2017
The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus MacaquesTrudy H Grossman, Michael S Anderson, Lindsay Drabek, et al.
Science (New York, N.Y.)|October 20, 2022
Time-restricted feeding mitigates obesity through adipocyte thermogenesisChelsea Hepler, Benjamin J Weidemann, Nathan J Waldeck, et al.
Journal of Medicinal Chemistry|May 16, 2014
Antibacterial inhibitors of Gram-positive thymidylate kinase: structure-activity relationships and chiral preference of a new hydrophobic binding regionSameer P Kawatkar, Thomas A Keating, Nelson B Olivier, et al.
Pageof 15